Positive rate of malignant cells in endometrial cytology samples of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer patients: A systematic review and meta-analysis

To estimate the feasibility of diagnosing ovarian cancer, fallopian tube cancer, and primary peritoneal cancer through endometrial cytology, we performed a systematic review and meta-analysis to calculate the pooled positive rate of malignant cells in endometrial cytology samples. We queried PubMed,...

Full description

Bibliographic Details
Main Authors: Tiantian Wang, Yadi Bin, Lanbo Zhao, Qiling Li
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Journal of Cytology
Subjects:
Online Access:http://www.jcytol.org/article.asp?issn=0970-9371;year=2023;volume=40;issue=2;spage=51;epage=57;aulast=Wang
_version_ 1797773956494655488
author Tiantian Wang
Yadi Bin
Lanbo Zhao
Qiling Li
author_facet Tiantian Wang
Yadi Bin
Lanbo Zhao
Qiling Li
author_sort Tiantian Wang
collection DOAJ
description To estimate the feasibility of diagnosing ovarian cancer, fallopian tube cancer, and primary peritoneal cancer through endometrial cytology, we performed a systematic review and meta-analysis to calculate the pooled positive rate of malignant cells in endometrial cytology samples. We queried PubMed, EMBASE, Medline, and Cochrane Central Register of Controlled Trails from inception to November 12, 2020 for studies estimating positive rates of malignant cells in endometrial cytology samples from patients with ovarian cancer, fallopian tube cancer, and primary peritoneal cancer. The positive rates of the included studies were calculated as pooled positive rate through meta-analyses of proportion. Subgroup analysis based on different sampling methods was conducted. Seven retrospective studies involving 975 patients were included. Pooled positive rate of malignant cells in endometrial cytology specimens of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer patients was 23% (95% CI: 16% - 34%). Statistical heterogeneity between the included studies was considerable (I2 = 89%, P < 0.01). The pooled positive rates of the group of brushes and the group of aspiration smears were 13% (95% CI: 10% - 17%, I2 = 0, P = 0.45) and 33% (95% CI: 25% - 42%, I2 = 80%, P < 0.01), respectively. Although endometrial cytology is not an ideal diagnostic tool for ovarian cancer, fallopian tube cancer, and primary peritoneal cancer, it is a convenient, painless, and easy-to-implement adjunct to other tools. Sampling method is one of the factors that affect the detection rate.
first_indexed 2024-03-12T22:13:44Z
format Article
id doaj.art-6f748b33f02046c28363dfc60e0885d2
institution Directory Open Access Journal
issn 0970-9371
language English
last_indexed 2024-03-12T22:13:44Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Cytology
spelling doaj.art-6f748b33f02046c28363dfc60e0885d22023-07-23T11:26:17ZengWolters Kluwer Medknow PublicationsJournal of Cytology0970-93712023-01-01402515710.4103/joc.joc_49_22Positive rate of malignant cells in endometrial cytology samples of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer patients: A systematic review and meta-analysisTiantian WangYadi BinLanbo ZhaoQiling LiTo estimate the feasibility of diagnosing ovarian cancer, fallopian tube cancer, and primary peritoneal cancer through endometrial cytology, we performed a systematic review and meta-analysis to calculate the pooled positive rate of malignant cells in endometrial cytology samples. We queried PubMed, EMBASE, Medline, and Cochrane Central Register of Controlled Trails from inception to November 12, 2020 for studies estimating positive rates of malignant cells in endometrial cytology samples from patients with ovarian cancer, fallopian tube cancer, and primary peritoneal cancer. The positive rates of the included studies were calculated as pooled positive rate through meta-analyses of proportion. Subgroup analysis based on different sampling methods was conducted. Seven retrospective studies involving 975 patients were included. Pooled positive rate of malignant cells in endometrial cytology specimens of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer patients was 23% (95% CI: 16% - 34%). Statistical heterogeneity between the included studies was considerable (I2 = 89%, P < 0.01). The pooled positive rates of the group of brushes and the group of aspiration smears were 13% (95% CI: 10% - 17%, I2 = 0, P = 0.45) and 33% (95% CI: 25% - 42%, I2 = 80%, P < 0.01), respectively. Although endometrial cytology is not an ideal diagnostic tool for ovarian cancer, fallopian tube cancer, and primary peritoneal cancer, it is a convenient, painless, and easy-to-implement adjunct to other tools. Sampling method is one of the factors that affect the detection rate.http://www.jcytol.org/article.asp?issn=0970-9371;year=2023;volume=40;issue=2;spage=51;epage=57;aulast=Wangdetection rateendometrial cytologymalignant cellovarian tumor
spellingShingle Tiantian Wang
Yadi Bin
Lanbo Zhao
Qiling Li
Positive rate of malignant cells in endometrial cytology samples of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer patients: A systematic review and meta-analysis
Journal of Cytology
detection rate
endometrial cytology
malignant cell
ovarian tumor
title Positive rate of malignant cells in endometrial cytology samples of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer patients: A systematic review and meta-analysis
title_full Positive rate of malignant cells in endometrial cytology samples of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer patients: A systematic review and meta-analysis
title_fullStr Positive rate of malignant cells in endometrial cytology samples of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer patients: A systematic review and meta-analysis
title_full_unstemmed Positive rate of malignant cells in endometrial cytology samples of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer patients: A systematic review and meta-analysis
title_short Positive rate of malignant cells in endometrial cytology samples of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer patients: A systematic review and meta-analysis
title_sort positive rate of malignant cells in endometrial cytology samples of ovarian cancer fallopian tube cancer and primary peritoneal cancer patients a systematic review and meta analysis
topic detection rate
endometrial cytology
malignant cell
ovarian tumor
url http://www.jcytol.org/article.asp?issn=0970-9371;year=2023;volume=40;issue=2;spage=51;epage=57;aulast=Wang
work_keys_str_mv AT tiantianwang positiverateofmalignantcellsinendometrialcytologysamplesofovariancancerfallopiantubecancerandprimaryperitonealcancerpatientsasystematicreviewandmetaanalysis
AT yadibin positiverateofmalignantcellsinendometrialcytologysamplesofovariancancerfallopiantubecancerandprimaryperitonealcancerpatientsasystematicreviewandmetaanalysis
AT lanbozhao positiverateofmalignantcellsinendometrialcytologysamplesofovariancancerfallopiantubecancerandprimaryperitonealcancerpatientsasystematicreviewandmetaanalysis
AT qilingli positiverateofmalignantcellsinendometrialcytologysamplesofovariancancerfallopiantubecancerandprimaryperitonealcancerpatientsasystematicreviewandmetaanalysis